Joseph Petroziello, BSc, MSc
Joe Petroziello is formerly Head of Communications at Juno Therapeutics, with specialization in executing scientific and corporate communications plans in collaboration with leading chimeric antigen receptor (CAR)-T cell academic institutions for development of novel cellular therapeutics, including Lisocabtagene Maraleucel (Liso-cel; JCAR017), an investigational CD19-Directed (CAR-T) cell therapy in pivotal-stage trials for non-Hodgkin lymphoma (NHL). Joe oversees Scientific & Corporate Communications at BrainStorm and provides strategic leadership for planned dissemination of scientific and clinical communications to drive public relations initiatives. Joe was formerly Vice President at consulting medical communications agencies in New York City, with specialization in strategic leadership of Scientific Communication Plans and Global Medical Affairs Plans.
Mr. Petroziello also worked at Seattle Genetics as Head of Antigen Discovery, leading Translational Research to identify and patent novel tumor-associated antigens for drug targeting as antibody-drug conjugates (ADCs) for cancers.
Mr. Petroziello received his BSc in Biological Sciences (1992) and MSc in Chemistry (1996) from the University of Scranton in Scranton, Pennsylvania.